Evolution of Walking Abilities in Subacute Stroke Patients Hospitalized in Neurorehabilitation Center
NCT ID: NCT06327035
Last Updated: 2024-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
400 participants
OBSERVATIONAL
2024-03-26
2025-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determinants of Balance Recovery After Stroke - Retrospective Study
NCT03203109
Stability of Hemiparetic Patients During a Daily Complex Task
NCT07082036
The Multitasking Rehabilitation She Enhanced Walking Speed Compared to the Simple Post Stroke Rehabilitation Task (AVC)?
NCT03009773
Gait Recovery After Stroke
NCT06806748
Evolution of the Patient's Perception of the Use of the Upper Limb After a Stroke During Intensive Rehabilitation
NCT06569771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gait rehabilitation
Assessment of gait and balance abilities after stroke during neurorehabilitation from the subacute phase of stroke to 6 months after stroke.
The assessments will be carried out on entrance to the neurological center, then at 1 ,3 and 6 months and on hospital discharge.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliated to a social security scheme
Exclusion Criteria
* Neurodegenerative disease impacting gait prior to stroke onset
* Patient not walking before stroke
* Progressive pathology with life-threatening consequences within 6 months
* Patient under legal protection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Le Normandy
UNKNOWN
Clinique Les Trois Soleils
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christophe T Duret, MD
Role: PRINCIPAL_INVESTIGATOR
Les Trois Soleils
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Le Normandy
Granville, Normandy, France
Clinique Les Trois Soleils
Boissise-le-Roi, , France
La Clinique Les Trois Soleils
Boissise-le-Roi, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ophélie Pila, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A02660-45
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.